PT Asuransi Ramayana Tbk (ISX:ASRM) Research & Development: Rp0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ISX:ASRM PT Asuransi Ramayana Tbk ISX:ASRM
55 GF Score
Price Rp250.00
GF Value Rp254.21
Valuation Fairly Valued
! 3 Warning Signs
View Full Analysis

What is PT Asuransi Ramayana Tbk Research & Development?

PT Asuransi Ramayana Tbk ISX:ASRM +0.81% 55 Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus rates ISX:ASRM with a GF Score™ of 55/100 and a GF Value™ of Rp254.21 (Fairly Valued). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PT Asuransi Ramayana Tbk's Research & Development for the three months ended in Mar. 2026 was Rp0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was Rp0 Mil.

PT Asuransi Ramayana Tbk  (ISX:ASRM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PT Asuransi Ramayana Tbk Research & Development Related Terms

PT Asuransi Ramayana Tbk Research & Development Historical Data

* Premium members only.

The historical data trend for PT Asuransi Ramayana Tbk's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Asuransi Ramayana Tbk Research & Development Chart

PT Asuransi Ramayana Tbk Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

PT Asuransi Ramayana Tbk Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ISX:ASRM
55GF Score
PT Asuransi Ramayana Tbk ISX:ASRM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PT Asuransi Ramayana Tbk Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of Rp0 Mil mean?
PT Asuransi Ramayana Tbk (ISX:ASRM) has a Research & Development of Rp0 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on PT Asuransi Ramayana Tbk and its competitors.
Is PT Asuransi Ramayana Tbk's Research & Development too high?
PT Asuransi Ramayana Tbk's current Research & Development is Rp0 Mil. Overall, PT Asuransi Ramayana Tbk has a GF Score™ of 55/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PT Asuransi Ramayana Tbk's Research & Development compare to CB and PGR?
PT Asuransi Ramayana Tbk's Research & Development of Rp0 Mil can be compared against companies in the Insurance industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for an Insurance company?
A good Research & Development depends on the Insurance industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PT Asuransi Ramayana Tbk and its competitors. PT Asuransi Ramayana Tbk's current Research & Development is Rp0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Asuransi Ramayana Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Asuransi Ramayana Tbk (ISX:ASRM) is currently considered Fairly Valued. The stock's GF Value™ is Rp254.21, compared to a current price of Rp250.00 — trading 1.7% below its estimated fair value. The current Research & Development is Rp0 Mil. PT Asuransi Ramayana Tbk's overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PT Asuransi Ramayana Tbk (ISX:ASRM), the current Research & Development is Rp0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is PT Asuransi Ramayana Tbk (ISX:ASRM) Overvalued in 2026?

Based on GuruFocus' analysis, PT Asuransi Ramayana Tbk stock appears to be undervalued. The current stock price of Rp250.00 is trading 1.7% below its estimated GF Value™ of Rp254.21. GuruFocus considers PT Asuransi Ramayana Tbk to be Fairly Valued.

Key valuation signals for ISX:ASRM:

  • Research & Development: Rp0 Mil
  • GF Value™: Rp254.21 vs. price of Rp250.00 (1.7% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the ISX:ASRM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

PT Asuransi Ramayana Tbk Business Description

Address Jalan Kebon Sirih No. 49, Jakarta, IDN, 10340
PT Asuransi Ramayana Tbk is an Indonesia-based company engaged in the general insurance business. The products of the company include property insurance, motor vehicle insurance, engineering insurance, marine insurance, health insurance, aviation insurance, electronic equipment insurance, machinery breakdown insurance, personal accident insurance, money insurance, surety bonds, and others. The firm operates through the General Insurance and Office Building Rental segments.
55GF Score

Get the complete analysis for ISX:ASRM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

Rp250.00
Price
Rp254.21
GF Value